News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Goddard Glenn
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2023 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 2,427 shares
@ $37.21, valued at
$90.3k
|
|
| 01/04/2023 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 3,062 restricted stock units
@ $0 |
|
| 03/04/2022 |
4/A
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 18,600 options to buy
@ $79.85, valued at
$1.5M
|
|
| 03/03/2022 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 1,013 shares
@ $112.24, valued at
$113.7k
Granted 12,720 shares
@ $0
Exercised 3,062 restricted stock units
@ $0
Granted 12,720 options to buy
@ $79.85, valued at
$1M
|
|
| 09/09/2021 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 3,482 shares
@ $180.12, valued at
$627.2k
Exercised 3,482 options to buy
@ $14.58, valued at
$50.8k
|
|
| 09/01/2021 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 704 shares
@ $153.22, valued at
$107.9k
Sold 1,100 shares
@ $154.29, valued at
$169.7k
Sold 1,700 shares
@ $155.29, valued at
$264k
Sold 300 shares
@ $156.1, valued at
$46.8k
Sold 496 shares
@ $157.33, valued at
$78k
Sold 300 shares
@ $158.42, valued at
$47.5k
Sold 300 shares
@ $159.53, valued at
$47.9k
Sold 300 shares
@ $160.84, valued at
$48.3k
Sold 24,800 shares
@ $160.22, valued at
$4M
Exercised 5,200 options to buy
@ $19.27, valued at
$100.2k
Exercised 22,983 options to buy
@ $19.27, valued at
$442.9k
|
|
| 08/06/2021 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 9,902 shares
@ $150.65, valued at
$1.5M
Sold 9,568 shares
@ $151.41, valued at
$1.4M
Sold 530 shares
@ $152.13, valued at
$80.6k
Exercised 20,000 options to buy
@ $19.27, valued at
$385.4k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2018 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 17,750 options to buy
@ $14.58, valued at
$258.8k
|
|
| 12/20/2018 |
4/A
| Goddard Glenn (See Remarks) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $19.27, valued at
$1.7M
|
|
| 11/01/2018 |
4
| Goddard Glenn (SEE REMARKS) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $19.27, valued at
$1.7M
|
|
| 10/29/2018 |
3
| Goddard Glenn (See Remarks) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 02/18/2016 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 20,330 options to buy
@ $39.76, valued at
$808.3k
|
|
| 09/28/2015 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 4,856 shares
@ $88.89, valued at
$431.6k
Sold 6,000 shares
@ $85.97, valued at
$515.8k
Exercised 10,000 restricted stock units
@ $0
Exercised 856 options to buy
@ $23.1, valued at
$19.8k
|
|
| 07/27/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/21/2015 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 13,000 shares
@ $113.71, valued at
$1.5M
Exercised 909 options to buy
@ $0.6875, valued at
$624.9
Exercised 7,273 options to buy
@ $2.34, valued at
$17k
Exercised 3,725 options to buy
@ $9.05, valued at
$33.7k
Exercised 1,093 options to buy
@ $23.1, valued at
$25.2k
|
|
| 05/28/2015 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,171 shares
@ $120.05, valued at
$260.6k
Exercised 2,171 options to buy
@ $23.1, valued at
$50.2k
|
|
| 03/18/2015 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 455 shares
@ $0.69, valued at
$314
Sold 10,000 shares
@ $106.24, valued at
$1.1M
Exercised 455 options to buy
@ $0.6875, valued at
$312.8
Exercised 3,477 options to buy
@ $23.1, valued at
$80.3k
Exercised 6,068 options to buy
@ $31.64, valued at
$192k
|
|
| 03/03/2015 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 30,600 options to buy
@ $107.89, valued at
$3.3M
|
|
| 02/17/2015 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 1,316 shares
@ $120.31, valued at
$158.3k
Exercised 1,316 options to buy
@ $23.1, valued at
$30.4k
|
|
| 02/11/2015 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 15,000 shares
@ $105.81, valued at
$1.6M
Sold 1,513 shares
@ $120.14, valued at
$181.8k
Exercised 681 options to buy
@ $0.6875, valued at
$468.2
Exercised 14,319 options to buy
@ $23.1, valued at
$330.8k
Exercised 1,513 options to buy
@ $23.1, valued at
$35k
|
|
| 11/04/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,000 shares
@ $81.71, valued at
$163.4k
Exercised 228 options to buy
@ $0.6875, valued at
$156.8
Exercised 1,772 options to buy
@ $9.05, valued at
$16k
|
|
| 10/03/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 1,500 shares
@ $60.07, valued at
$90.1k
Exercised 1,500 options to buy
@ $9.05, valued at
$13.6k
|
|
| 09/29/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 17,500 shares
@ $56.53, valued at
$989.3k
Exercised 227 options to buy
@ $0.6875, valued at
$156.1
Exercised 9,725 options to buy
@ $2.34, valued at
$22.8k
Exercised 7,548 options to buy
@ $9.05, valued at
$68.3k
|
|
| 09/26/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 09/03/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $46.3, valued at
$463k
Exercised 455 options to buy
@ $0.6875, valued at
$312.8
Exercised 9,545 options to buy
@ $2.34, valued at
$22.3k
|
|
| 07/02/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 3,500 shares
@ $46.52, valued at
$162.8k
Exercised 1,894 options to buy
@ $0.4675, valued at
$885.4
Exercised 454 options to buy
@ $0.6875, valued at
$312.1
Exercised 1,152 options to buy
@ $2.34, valued at
$2.7k
|
|
| 05/05/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 947 shares
@ $0.4675, valued at
$442.7
Exercised 227 shares
@ $0.6875, valued at
$156.1
Exercised 826 shares
@ $2.34, valued at
$1.9k
Sold 2,000 shares
@ $42.39, valued at
$84.8k
Disposed/sold 947 options to buy
@ $0.4675, valued at
$442.7
Disposed/sold 227 options to buy
@ $0.6875, valued at
$156.1
Disposed/sold 826 options to buy
@ $2.34, valued at
$1.9k
|
|
| 04/08/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 1,431 shares
@ $0.6875, valued at
$983.8
Exercised 569 shares
@ $2.34, valued at
$1.3k
Sold 2,000 shares
@ $45.17, valued at
$90.3k
Granted 21,818 options to buy
@ $2.34, valued at
$51.1k
Granted 10,909 options to buy
@ $9.05, valued at
$98.7k
Disposed/sold 1,431 options to buy
@ $0.6875, valued at
$983.8
Disposed/sold 569 options to buy
@ $2.34, valued at
$1.3k
|
|
| 04/03/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 4,000 shares
@ $38.08, valued at
$152.3k
Exercised 947 options to buy
@ $0.4675, valued at
$442.7
Exercised 3,053 options to buy
@ $0.6875, valued at
$2.1k
|
|
| 03/07/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 5,468 shares
@ $35.54, valued at
$194.3k
Sold 12,000 shares
@ $45.1, valued at
$541.2k
Granted 40,000 options to buy
@ $31.64, valued at
$1.3M
Exercised 5,468 options to buy
@ $0.4675, valued at
$2.6k
Exercised 9,666 options to buy
@ $0.4675, valued at
$4.5k
Exercised 2,334 options to buy
@ $0.6875, valued at
$1.6k
|
|
| 02/20/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 3,532 shares
@ $35.06, valued at
$123.8k
Exercised 3,532 options to buy
@ $0.4675, valued at
$1.7k
|
|
| 02/11/2014 |
4
| Goddard Glenn (Senior Vice President, Finance) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 6,000 shares
@ $30.44, valued at
$182.6k
Exercised 6,000 options to buy
@ $0.4675, valued at
$2.8k
|
|
|
|
|